Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Harnessing autophagy for adoptive T-cell therapy.

Literature DB >> 22149992

Harnessing autophagy for adoptive T-cell therapy.

Shoba Amarnath, Daniel H Fowler.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2012 PMID： 22149992 PMCID： PMC3249636 DOI： 10.2217/imt.11.144

Source DB: PubMed Journal: Immunotherapy ISSN： 1750-743X Impact factor: 4.196

× No keyword cloud information.

24 in total

1. Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD.

Authors: Shoba Amarnath; Francis A Flomerfelt; Carliann M Costanzo; Jason E Foley; Jacopo Mariotti; Daniel M Konecki; Anu Gangopadhyay; Michael Eckhaus; Susan Wong; Bruce L Levine; Carl H June; Daniel H Fowler
Journal: Autophagy Date: 2010-05-16 Impact factor: 16.016

2. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.

Authors: David L Porter; Bruce L Levine; Michael Kalos; Adam Bagg; Carl H June
Journal: N Engl J Med Date: 2011-08-10 Impact factor: 91.245

3. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1.

Authors: Paul F Robbins; Richard A Morgan; Steven A Feldman; James C Yang; Richard M Sherry; Mark E Dudley; John R Wunderlich; Azam V Nahvi; Lee J Helman; Crystal L Mackall; Udai S Kammula; Marybeth S Hughes; Nicholas P Restifo; Mark Raffeld; Chyi-Chia Richard Lee; Catherine L Levy; Yong F Li; Mona El-Gamil; Susan L Schwarz; Carolyn Laurencot; Steven A Rosenberg
Journal: J Clin Oncol Date: 2011-01-31 Impact factor: 44.544

4. Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy.

Authors: Christian S Hinrichs; Zachary A Borman; Luca Gattinoni; Zhiya Yu; William R Burns; Jianping Huang; Christopher A Klebanoff; Laura A Johnson; Sid P Kerkar; Shicheng Yang; Pawel Muranski; Douglas C Palmer; Christopher D Scott; Richard A Morgan; Paul F Robbins; Steven A Rosenberg; Nicholas P Restifo
Journal: Blood Date: 2010-10-22 Impact factor: 22.113

Review 5. Allogeneic transplantation for lymphoma.

Authors: Ronjon Chakraverty; Stephen Mackinnon
Journal: J Clin Oncol Date: 2011-04-11 Impact factor: 44.544

6. Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent.

Authors: Andrey Parkhitko; Faina Myachina; Tasha A Morrison; Khadijah M Hindi; Neil Auricchio; Magdalena Karbowniczek; J Julia Wu; Toren Finkel; David J Kwiatkowski; Jane J Yu; Elizabeth Petri Henske
Journal: Proc Natl Acad Sci U S A Date: 2011-07-11 Impact factor: 11.205

Review 7. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells.

Authors: John J O'Shea; William E Paul
Journal: Science Date: 2010-02-26 Impact factor: 47.728

8. Akt and autophagy cooperate to promote survival of drug-resistant glioma.

Authors: Qi-Wen Fan; Christine Cheng; Chris Hackett; Morri Feldman; Benjamin T Houseman; Theodore Nicolaides; Daphne Haas-Kogan; C David James; Scott A Oakes; Jayanta Debnath; Kevan M Shokat; William A Weiss
Journal: Sci Signal Date: 2010-11-09 Impact factor: 8.192

Review 9. The complex interplay between autophagy, apoptosis, and necrotic signals promotes T-cell homeostasis.

Authors: Craig M Walsh; Aimee L Edinger
Journal: Immunol Rev Date: 2010-07 Impact factor: 12.988

10. Host-based Th2 cell therapy for prolongation of cardiac allograft viability.

Authors: Shoba Amarnath; Hao Chen; Jason E Foley; Carliann M Costanzo; Joel D Sennesh; Michael A Solomon; Daniel H Fowler
Journal: PLoS One Date: 2011-04-29 Impact factor: 3.240

6 in total

1. Harnessing autophagy for cell fate control gene therapy.

Authors: Tania C Felizardo; Jason Foley; Kevin Steed; Boro Dropulic; Shoba Amarnath; Jeffrey A Medin; Daniel H Fowler
Journal: Autophagy Date: 2013-04-17 Impact factor: 16.016

Review 2. Rapamycin-resistant effector T-cell therapy.

Authors: Daniel H Fowler
Journal: Immunol Rev Date: 2014-01 Impact factor: 12.988

3. Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cells.

Authors: Luciano Castiello; Miriam Mossoba; Antonella Viterbo; Marianna Sabatino; Vicki Fellowes; Jason E Foley; Matthew Winterton; David C Halverson; Sara Civini; Ping Jin; Daniel H Fowler; David F Stroncek
Journal: Cytotherapy Date: 2013-01-24 Impact factor: 5.414